Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Intuitive Da Vinci Robotic Device To Enter Heart Surgery Market By Year End

This article was originally published in The Gray Sheet

Executive Summary

Intuitive Surgical expects to gain 510(k) clearance for expanded use of its da Vinci robotic surgical system for mitral valve repair and atrial septal defect closure by year-end

You may also be interested in...



Computer-Guided Endoscopic Catheter System Launch Set For 2004

A computer-guided endoscopic catheter placement system is initially being developed by endoVia Medical for less invasive gastrointestinal procedures, including treatment of esophageal reflux disease and obesity. A 510(k) filing is planned for January 2004

Computer-Guided Endoscopic Catheter System Launch Set For 2004

A computer-guided endoscopic catheter placement system is initially being developed by endoVia Medical for less invasive gastrointestinal procedures, including treatment of esophageal reflux disease and obesity. A 510(k) filing is planned for January 2004

Computer Motion

Zeus robotic surgical system manufacturer anticipates 510(k) clearance for general laparoscopic surgery indication to occur within "the next four to five weeks," Chairman and CEO Bob Duggan tells investors during a July 15 second-quarter earnings call. After receiving clearance, the firm plans to file a 510(k) for thoracic surgery. The company hopes that the two additional indications will even the playing field with competitor Intuitive Surgical (1"The Gray Sheet" March 4, 2002, p. 18). Computer Motion reported sales of $5.1 mil., up 27% over the same period last year, while its net loss was $4.9 mil., down 7%...

Related Content

UsernamePublicRestriction

Register

MT016190

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel